Vitamin B-6 Supplementation Could Mediate Antioxidant Capacity by Reducing Plasma Homocysteine Concentration in Patients with Hepatocellular Carcinoma after Tumor Resection

Table 1

Demographic and health characteristics of subjects¹.

	Placebo ()	Vitamin B-6 ()
Age (y)	61.0 ± 2.7	56.7 ± 3.6
Sex (male/female)	9/7	13/4
Body mass index (kg/m^2)	25.1 ± 1.0	24.6 ± 0.8
Blood pressure (mmHg)
Systolic	130.4 ± 5.1	125.0 ± 3.3
Diastolic	73.6 ± 3.0	74.9 ± 3.0
Serum albumin (g/dL)	4.1 ± 0.1	4.4 ± 0.1
Serum creatinine (mg/dL)	0.8 ± 0.1	0.9 ± 0.1
Cancer stage (, %)
Stage I	9 (56.3%)	11 (64.8%)
Stage II	7 (43.8%)	6 (35.3%)
Histological grading (, %)
Well differentiated (I)	1 (6.3%)	1 (5.9%)
Moderate differentiated (II)	3 (18.8%)	4 (23.5%)
Poor differentiated (III)	12 (75%)	12 (70.6%)
Smoking (, %)
Yes	4 (25%)	4 (23.5%)
No	12 (75%)	13 (76.5%)
Drinking (, %)
Yes	3 (18.8%)	2 (11.8%)
No	13 (81.3%)	15 (88.2%)

Values are means ± standard error of mean (SE).